NANO MRNA Co.,Ltd. (4571.T) JPX

132.00

+2(+1.54%)

Updated at October 03 03:30PM

Currency In JPY

NANO MRNA Co.,Ltd.

Address

Onoya-Kyobashi Building

Tokyo, 104-0031

Japan

Phone

81 3 3241 0550

Sector

Healthcare

Industry

Biotechnology

Employees

18

First IPO Date

March 05, 2008

Key Executives

NameTitlePayYear Born
Dr. Shiro Akinaga Ph.D.President, Chief Executive Officer & Representative Director01956
Mr. Atsushi MatsumuraExecutive Chairman of the Board01962
Mr. Koji FujimotoExecutive Officer & Chief Financial Officer01972

Description

NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Tokyo, Japan.